期刊文献+

2010—2016年耐碳青霉烯类肺炎克雷伯菌及大肠埃希菌临床分布及其耐药特征 被引量:59

Distribution and antimicrobial resistance of carbapenem-resistant Klebsiella pneumoniae and Escherichia coli in 2010-2016
下载PDF
导出
摘要 目的了解临床分离的耐碳青霉烯类肺炎克雷伯菌(CRKP)及耐碳青霉烯类大肠埃希菌(CREC)的临床分布状况及耐药特征。方法回顾性分析某院2010年1月—2016年12月临床标本分离的肺炎克雷伯菌及大肠埃希菌,统计分析CRKP及CREC分离情况。结果 2010—2016年7年共收集临床分离耐碳青霉烯类肠杆菌科细菌(CRE)310株(CRKP268株,CREC42株),CRKP检出率由2010年的1.33%上升到2016年的12.70%,呈逐年上升趋势(χ2=123.73,P<0.01);CREC检出率则处于相对稳定状态,2010—2016年均约为1.00%;标本来源和病区分布最多者分别为呼吸道标本(45.49%)和重症监护病房(31.93%)。药敏试验结果显示,CRKP和CREC除对阿米卡星耐药率稍低(分别为80.60%、38.10%)外,对大多数临床常用抗菌药物如第三代头孢菌素类、第四代头孢菌素类、β-内酰胺类/酶抑制剂类、喹诺酮类等耐药率CRKP均>90%、CREC均在80%左右,而非CRE菌株的耐药率低于CRE菌株(P<0.01)。结论 7年间临床分离的CRKP的检出率呈现快速增加的趋势,几乎对常用抗菌药物均耐药,应予以高度关注。 Objective To understand the clinical distribution and antimicrobial resistance characteristics of clinically isolated carbapenemresistant Klebsiella pneumoniae (CRKP) and carbapenemresistant Escherichia coli (CREC). MethodsClinically isolated Klebsiella pneumoniae and Escherichia coli from a hospital between January 2010 and December 2016 were analyzed retrospectively, isolation of CRKP and CREC were conducted statistical analysis. ResultsFrom 2010 to 2016, a total of 310 carbapenemresistant Enterobacteriaceae (CRE) isolates (268 were CRKP strains and 42 were CREC strains) were collected, isolation rate of CRKP increased from 1.33% in 2010 to 12.70% in 2016, showing an increasing trend year by year (χ2=123.73, P〈 0.01); isolation rate of CREC was relatively stable, were all about 1.00% from 2010 to 2016. Most specimens were respiratory tract specimens (45.49%) and from intensive care unit (31.93%). Antimicrobial susceptibility testing showed that except resistance rates of CRKP and CREC were slightly lower to amikacin (80.60% and 38.10% respectively), resistance rates of CRKP to most commonly used antimicrobial agents, such as third generation cephalosporins, fourth generation cephalosporins, βlactamase/lactamase inhibitors, and quinolones were all〉90%, resistance rates of CREC to above antimicrobial agents were all about 80%, resistance rate of nonCRE strains was lower than that of CRE strains (P〈0.01). ConclusionDuring the past 7 years, detection rate of clinically isolated CRKP increased rapidly, were almost resistant to commonly used antimicrobial agents, which should be paid close attention.
作者 徐红云 刘春林 陈弟 龙湖波 李红 马众仙 张唤 杨宝瑞 杨文波 余林 刘畅 李宜铮 XU Hongyun;LIU Chunlin;CHEN Di;LONG Hubo;LI Hong;MA Zhongxian;ZHANG Huan;YANG Baorui;YANG Wenbo;YU Lin;LIU Chang;LI Yizheng(The Second People's Hospital of Yunnan Province,Kunming 650021,China)
出处 《中国感染控制杂志》 CAS 北大核心 2018年第8期688-692,共5页 Chinese Journal of Infection Control
关键词 肺炎克雷伯菌 大肠埃希菌 耐碳青霉烯类肺炎克雷伯菌 耐碳青霉烯类大肠埃希菌 碳青霉烯酶 耐药性 抗药性 微生物 Klebsiella pneumoniae Escherichia coli carbapenemresistant Klebsiella pneumoniae carbapenemresistant Escherichia coli carbapenemase drug resistance microbial
  • 相关文献

参考文献3

  • 1胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,郭素芳,魏莲花,吴玲,张泓,王春,胡云建,艾效曼,卓超,苏丹虹,汪瑞忠,房华,俞碧霞,赵勇,龚萍.2015年CHINET细菌耐药性监测[J].中国感染与化疗杂志,2016,16(6):685-694. 被引量:390
  • 2徐安,卓超,苏丹虹,胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,孙自镛,陈中举,倪语星,孙景勇,胡志东,李金,张朝霞,季萍,王传清,王爱敏,杨青,徐元宏,沈继录,单斌,杜艳,张泓,孔菁,魏莲花,吴玲,谢轶,康梅,胡云建,艾效曼,俞云松,林洁,黄文祥,贾蓓,禇云卓,田素飞,韩艳秋,郭素芳.2005-2014年CHINET克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2016,16(3):267-274. 被引量:122
  • 3陈越,倪语星,孙景勇.2005-2014年上海交通大学医学院附属瑞金医院细菌耐药性监测[J].中国感染与化疗杂志,2016,16(6):695-705. 被引量:2

二级参考文献39

  • 1朱德妹,张婴元,汪复,郭燕,蒋晓飞,倪语星,孙景勇,应春妹,汪雅萍,王传清,王爱敏,蒋燕群,汤瑾,张泓,李万华,沈燕雅,金文敏,周庭银,陈险峰,张蓓,黄卫春,杨海慧,卫颖珏,汤荣,丁星,吴丽桂,武楠,汪瑞忠,房华,吕新华,朱爱英.2009年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):403-413. 被引量:37
  • 2汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 3朱德妹,汪复,张婴元.2005年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2006,6(6):371-376. 被引量:82
  • 4朱德妹,张婴元,汪复.2006年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2007,7(6):393-399. 被引量:100
  • 5汪复.2006年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2008,8(1):1-9. 被引量:281
  • 6Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing [S].Twenty- Fourth Informational Supplement,2014,M100-S24.
  • 7Pifzer Inc.Tygacil? Product Insert.Philadelphia,PA,2013[Z/OL].[2015-04-201.http://www.pfizerpro.com/hcp/tygacil.
  • 8MAGIORAKOS AP,SRINIVASAN A,CAREY RB,et al.Multidrug-resistant,extensively drug-resistant and pandrug- resistant bacteria:an international expert proposal for interim standard definitions for acquired resistance [J].Clin Microbiol Infect,2012,18(3):268-281.
  • 9SHON AS,BAJWA RP,RUSSA TA,et al.Hypervirulent (hypermucoviscous) Klebsiella pneumoniae:a new and dangerous breed[J].Virulence,2013,4(2):107-118.
  • 10LIU YM,LI BB,ZHANG YY,et al.Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in China's Mainland[J].Antimicrob Agents Chemother,2014,58(9):5379-5385.

共引文献490

同被引文献479

引证文献59

二级引证文献348

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部